4//SEC Filing
Molecular Insight Pharmaceuticals, Inc. 4
Accession 0001209191-07-067597
CIK 0001340752operating
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 3:58 PM ET
Size
10.6 KB
Accession
0001209191-07-067597
Insider Transaction Report
Form 4
Babich John W
DirectorPresident, CEO and CSO
Transactions
- Purchase
Common Stock
2007-11-30$8.34/sh+600$5,004→ 171,635 total - Purchase
Common Stock
2007-11-30$8.35/sh+1,900$15,865→ 173,535 total
Issuer
Molecular Insight Pharmaceuticals, Inc.
CIK 0001340752
Entity typeoperating
IncorporatedMA
Related Parties
1- filerCIK 0001340752
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 3:58 PM ET
- Size
- 10.6 KB